Streetbeat News

Analyst Ratings

AVDL

Needham analyst Ami Fadia has reiterated a 'Buy' rating on Avadel Pharmaceuticals (NASDAQ:AVDL) and maintained a price target of $18.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 10:50 am

USFD

US Foods Holding Corp. (NYSE:USFD) has updated its FY2023 guidance, raising its adjusted EPS from $2.45-$2.65 to $2.55-$2.65, compared to the analyst estimate of $2.56. The company also increased its adjusted EBITDA and interest expense guidance, while maintaining its net debt to adjusted EBITDA leverage below 3.0x by the end of FY2023.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 10:49 am

PAR

Needham analyst Mayank Tandon has reiterated a 'Buy' rating on PAR Technology (NYSE:PAR) and maintained a price target of $43.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 10:49 am

MDNA

HC Wainwright & Co. analyst Swayampakula Ramakanth has reiterated a 'Buy' rating on Medicenna Therapeutics (NASDAQ:MDNA) and maintained a price target of $2.5.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 10:46 am

HARP

HC Wainwright & Co. analyst Swayampakula Ramakanth has reiterated a 'Buy' rating on Harpoon Therapeutics (NASDAQ:HARP) and maintained a price target of $4.5.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 10:46 am

ECOR

HC Wainwright & Co. analyst Swayampakula Ramakanth has reiterated a 'Buy' rating on electroCore (NASDAQ:ECOR) and maintained a $10 price target.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 10:45 am

RWLK

HC Wainwright & Co. analyst Swayampakula Ramakanth has reiterated a 'Buy' rating on ReWalk Robotics (NASDAQ:RWLK) and maintained a $3 price target.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 10:43 am

PGEN

HC Wainwright & Co. analyst Swayampakula Ramakanth has reiterated a 'Buy' rating on Precigen (NASDAQ:PGEN) and maintained a $6 price target.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 10:42 am

AVDL

HC Wainwright & Co. analyst Oren Livnat has reiterated a 'Buy' rating on Avadel Pharmaceuticals (NASDAQ:AVDL) and maintained a price target of $21.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 10:41 am

ZNTL

HC Wainwright & Co. analyst Andrew Fein has reiterated a 'Buy' rating on Zentalis Pharma (NASDAQ:ZNTL) and maintained a $55 price target.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 10:40 am